期刊文献+

^(32)P-玻璃微球肝动脉栓塞对肝组织损伤的实验评估 被引量:1

valuation of radiation damage of transcatheter hepatic arterial embolization using phosphorus 32 glass microspheresin aswine model
原文传递
导出
摘要 目的 研究正常家猪对32P玻璃微球(32PGMS)肝动脉内栓塞后内放射性的急性和亚急性毒性反应,探讨32PGMS的临床应用安全性和使用安全剂量范围。方法 10 只正常家猪分为两组,实验组5 只,对照组5 只。分别用直径46 ~76 μm 的32PGMS和31PGMS作肝动脉栓塞。术后行血常规、肝肾功能等实验室检查,同时,行肝区和其他器官放射剂量分布等监测。术后1 、2、4、8 、16 周分别处死猪,行光学显微镜( 简称光镜) 和电子显微镜(简称电镜)检查。结果 32PGMS均匀分布于给药动脉营养的全肝或肝叶内,达汇管区肝最小动脉水平,实验室及病理均显示肝组织有轻微的损伤,但均为一过性,约在8 周左右恢复正常。肝组织损伤的超微结构改变以1~2 周内最明显。实验组所接受的32PGMS宏观平均吸收剂量为48~190 Gy。结论 用32PGMS行肝动脉栓塞为一有效、安全、可行的方法。 Objective To evaluatethe acuteand sub acutetoxicresponsetotranscatheterhepatic arterial emolization of Phosphorus 32 glass microspheres (32P GMS) in pigs- Methods Selective transcatheter hepatic arterialembolization was performedin10 healthy domestic pigsusing 46 -76 μm 32P GMS(5 pigs,48- 190 Gy) and nonradioactiveglass microspheres(5 pigs) ascontrolgroup- Bloodtestsincludingcomplete bloodcount,liver and kidneyfunctiontestswere measured- The distribution of32Pwas monitored- The pigs weresacrificedat1 ,2 ,4, 8 and16 weeks,respectively- Microscopicand ultrastructuralhistopathologyoftheliverand kidney wasevaluated- Results 32 P GMS was distributed evenly over the liver purfused- The GMS were located in the hepatic micrioarteriesandfew collateralfeeding arteries wereformed- Transientelevation oftransaminases wasobservedin allpigs following 32P GMSadministration- No evidence of myelosuppression was found- Swelling and vacuolar degeneration ofhepatocytesandlymphocyteinfiltrationintheliver were demonstratedinthe pigsinjected with 32P GMS- However,no hepatic parenchymal necrosis occurred- Conclusions This study suggests thatintraarterial hepatic administration of32P GMSwith doselessthan190 Gyis welltolerated-
出处 《中华放射学杂志》 CAS CSCD 北大核心 1999年第10期667-671,共5页 Chinese Journal of Radiology
基金 江苏省科委资助
关键词 肝癌 肝动脉 栓塞疗法 磷32玻璃微球 肝组织损伤 Phosphorusradioisotopes Microspheres Animals,laboratory Hepatic artery Embolization,therapeutic
  • 相关文献

参考文献12

二级参考文献4

  • 1宝建中,王一,詹镕洲,吴孟超.克隆化人肝癌裸鼠移植瘤株的建立及其转移性状观察[J].肿瘤防治研究,1995,22(2):65-67. 被引量:7
  • 2陈晓理,普外基础与临床杂志,1996年,3卷,68页
  • 3李立,普外基础与临床杂志,1995年,2卷,100页
  • 4Jeffrey A. Smith,Sharron H. Francis,Jackie D. Corbin. Autophosphorylation: a salient feature of protein kinases[J] 1993,Molecular and Cellular Biochemistry(1):51~70

共引文献101

同被引文献11

  • 1秦明秀 刁国平 等.临床介入核医学[M].天津:天津科学技术出版社,1996.209-241.
  • 2Nijsen F, Rook D, Brandt C, et al. Targeting of liver tumour in rats by selective delivery of holmium-166 loaded microspheres: a biodistribution study. Eur J Nucl Med, 2001, 28:743-749.
  • 3Campbell AM, Bailey IH, Burton MA. Analysis of the distribution of intra-arterial microspheres in human liver following hepatic yttrium-90 microsphere therapy. Phys Med Biol, 2000,45: 1023-1033.
  • 4Campbell AM, Bailey IH, Burton MA. Tumour dosimetry in human liver following hepatic yttrium-90 microsphere therapy. Phys Med Biol, 2001, 46:487-498.
  • 5Ho S, Lau WY, Leung TW, et al. Partition model for estimating radiation doses from yttrium-90 microspheres in treating hepatic tumours. Eur J Nucl Med, 1996, 23: 947-952.
  • 6Vokes EE, Weichselbaum RR. Concomitant chemoradiotherapy: rationale and clinical experience in patients with solid tumors(Review). J Clin Oncol, 1990,8:911-934.
  • 7Chenoufi N, Raoul JL, Lescoat G, et al. In vitro demonstration of synergy between radionuclide and chemotherapy. J Nucl Med, 1998,39:900-903.
  • 8Andrews JC, Walker SC, Ackermann RJ, et al. Hepatic Radioembolization with yttrium-90 containing glass microspheres: preliminary results and clinical follow-up. J Nucl Med, 1994, 35: 1637-1644.
  • 9Shepherd FA, Rotstein LE, Houle S, et al. A phase I dose escalation trial of yttrium-90 microspheres in the treatment of primary hepatocellular carcinoma. Cancer, 1992, 70:2250-2254.
  • 10Burton MA, Gray BN, Jones C, et al. Intraoperative dosimetry of 90Y in liver tissue. Int J Rad Appl Instrum B, 1989,16: 495-498.

引证文献1

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部